Theriva Biologics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.18

-0.02 (-8.95%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +20,926.1% upside

Low Target $26.34

Average Target $38.73

High Target $46.19

Current Price $0.18

Current
$0.18

Target
$38.73

$26.34 $38.73 avg $46.19

Scenario Analysis

Bear Case

$26.34

14,199.7%

Low target

Base Case

$38.73

+20,926.1%

Avg target

Bull Case

$46.19

+24,976.0%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$1.50

-87.7% from high

52-Week Low

$0.16

+13.1% from low

Target vs 52W High

$38.73

+2,482.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%